The use of oncofetal ferritin-bearing lymphocytes as a marker for the screening, diagnosis, and follow-up of patients with early breast malignancy screening of 3400 women.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples